Effectiveness and Safety Study for RWJ-333369 as Adjunctive Therapy in Korean and Japanese Patients With Partial Onset Seizures

NCT00697762 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
56
Enrollment
INDUSTRY
Sponsor class

Stopped The trial was stopped based on information from the global phase 3 studies.

Conditions

Interventions

Sponsor

SK Life Science, Inc.